Endocannabinoid System & Chronic Pain: Clinical Evidence Review
Clinical trials demonstrate cannabinoids for chronic pain clinical evidence with modest reductions in neuropathic and mixed pain. Benefits are often accompanied by adverse effects like dizziness and sedation. Patients and clinicians should weigh these…
Endocannabinoid System Research: Cannabis for Chronic Pain
The cannabinoids chronic pain evidence review 2025 highlights measurable but modest pain relief for chronic pain conditions. Effects vary based on THC-to-CBD ratio, cannabinoid source, and delivery method. Clinicians should weigh benefits against harms…
Study Finds Cannabis Use, Anxiety, and Depression Rising in Canada
A Canadian study highlights cannabis use anxiety treatment evidence by showing rising rates of cannabis use alongside anxiety and depression. The research reveals a consistent association between cannabis use and mood disorders. This evidence underscores…
Cannabis Dosing After 70: A Safe and Predictable Approach
Cannabis dosing variability is a critical consideration for seniors over 70. This guide offers a conservative framework prioritizing safety and predictability. Personalized dosing plans help minimize risks like dizziness and sedation.
Melt-Down Cannabis Gummies: Remix Flavor, Sourness, and Dose With a Simple Calculator
Melt down cannabis gummies gently to remix flavor, sourness, and dose with ease. Use the on-page calculator to dial in mg per piece for consistent potency. This method offers a faster way to make cannabis gummies without starting from scratch.
Cannabis and Anxiety Relief in Real-World Patients: A 45-Day Longitudinal Analysis
A 45-day longitudinal study tracked cannabis-use days anxiety relief in 416 medical cannabis patients. Cannabis-use days showed larger same-day reductions in anxiety compared to non-cannabis days. This real-world data highlights patient-reported benefits…
Adolescent Cannabis Use and Psychosis Risk: Study Insights and Limits
This article reviews an observational study cannabis psychosis risk focusing on adolescent cannabis use and later psychiatric diagnoses. It explains the study's binary exposure method and its limitations. Understanding this association helps clarify what…
Prenatal Cannabis Exposure Study: 9 Clear Findings
A new prenatal cannabis exposure study used meconium testing and Medicaid claims to examine well-child visits, ED use, and developmental delay coding. The headline is simple: no signal of increased utilization burden, and no higher developmental delay by…
Is Cannabis Safe for Seniors With Chronic Pain? What the Evidence Shows
Cannabis chronic pain older adults use is complex and nuanced. Some seniors report meaningful pain relief and reduced opioid use. However, risks like falls and drug interactions require careful consideration.
The Medicine Behind the Market : Part III/ IV — The Recovery: When the Market Learns to Heal
Healing rarely begins with profit; it starts with cannabis clinical literacy and pattern recognition. The recovery phase emerges as companies measure outcomes and respect the endocannabinoid system. This approach rebuilds trust and aligns economics with…
